Carbonite Launching Disaster Recovery as a Service (DRaaS) in 2018

15Nov

Carbonite Launching Disaster Recovery as a Service (DRaaS) in 2018

Portfolio News

Carbonite is preparing to launch a disaster recovery as a service (DRaaS) platform in the first half of 2018, according to CEO Mohamad Ali. Partners — including MSPs — will play a key role in delivering the DRaaS service to midmarket customers. Read more >>

Share this post

Related Posts

17Nov

Sysmex Selects Aras Innovator PLM

Aras, the next leader in enterprise product lifecycle management (PLM) software, announced Sysmex Corp., a leading international manufacturer of laboratory... read more
03Jun

eSight and the CNIB Foundation announce new scholarship program for students with sight loss

eSight, the world’s leading vision enhancement platform, is pleased to announce a new scholarship program in partnership with the CNIB... read more
26Aug

Wasabi: Beware The Hidden Cost Of Cloud Storage

‘We’re talking about easy, predictable pricing, no extraneous fees. We’re talking about performance that makes sure your data gets in... read more
26Jun

NEO has played critical role in success of Boston-based medical device maker

When Boston-based medical device company Myomo rang the bell of the New York Stock Exchange on June 16, it was... read more
28Dec

Elizabeth Banks on why she invested in popular canned-wine maker Archer Roose

Why she invested, in her own words -- I first learned about Archer Roose while floating down a river in... read more
11Sep

Life-changing technology is helping blind people see

But the future is looking bright, or rather, clear, for Kasandra these days. The 16-year-old sophomore is part of a growing... read more
23Nov

Skyline Medical (SKLN) Reports Approval in Canada to Market STREAMWAY System

Skyline Medical Inc. (NASDAQ: SKLN) announces that it has received a Medical Device Establishment License to sell the STREAMWAY System... read more
05Nov

India to Start Clinical Trials of US-Based Second Generation, Low-Cost Covid-19 Vaccine

India will soon start clinical trials of US-based Akston Biosciences second-generation Covid-19 vaccine — one of the most promising candidates... read more
20Jul

BrandVerge Names IRI as Recommended Audiences Provider

BrandVerge, a platform that connects media companies and advertisers, and IRI®, a fast-growing global technology leader in innovative solutions and... read more
18Oct

CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy

CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it... read more